Exclusion of active TB and treatment of latent tuberculosis infection (LTBI) are therefore clinical imperatives prior to starting anti-TNF therapy and active surveillance for a history of untreated or partially treated TB or LTBI has already been shown to be effective in reducing the number of incident TB cases [2,3]. This evidence concerns the gene TNF and tuberculosis.